PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; ...
Florida has many friendly small towns, but which ones are ideal for visitors? Here are the Sunshine State's 10 best, ...
The management of rheumatoid arthritis (RA) has significantly improved, but a substantial number of patients still experience ...
Britain's police state can today be unmasked as the Daily Mail can reveal which forces have made the most arrests for ...
Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...
Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...
Q3 2025 Earnings Call November 13, 2025 5:00 PM ESTCompany ParticipantsGuilherme Souto - Investor Relations Officer & Director ...
For patients across all indications treated within the RP2D range early, promising progression-free survival (PFS) and ...
Q3 2025 Earnings Call Transcript November 10, 2025 FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, ...
Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an ...
Quest Diagnostics Incorporated (DGX) 7th Annual Healthcare Symposium November 14, 2025 8:50 AM ESTCompany ParticipantsAsia ChangConference ...
From France rewriting its sexual assault laws to Morocco's Gen Z uprising to Trump's rare earth diplomacy in Asia, these ...